ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $12,487,000 | +206.3% | 3,045,999 | +166.6% | 0.02% | +214.3% |
| Q4 2021 | $4,077,000 | +220.8% | 1,142,491 | +226.8% | 0.01% | +250.0% |
| Q3 2021 | $1,271,000 | +211.5% | 349,593 | +101.9% | 0.00% | +100.0% |
| Q1 2020 | $408,000 | +101.0% | 173,156 | +300.1% | 0.00% | – |
| Q4 2019 | $203,000 | +40.0% | 43,281 | 0.0% | 0.00% | – |
| Q3 2019 | $145,000 | -89.0% | 43,281 | -90.0% | 0.00% | -100.0% |
| Q1 2019 | $1,316,000 | -51.0% | 434,594 | -56.0% | 0.00% | -66.7% |
| Q4 2018 | $2,686,000 | -28.0% | 988,812 | -11.0% | 0.01% | -14.3% |
| Q3 2018 | $3,732,000 | +27.4% | 1,110,597 | -2.2% | 0.01% | +16.7% |
| Q2 2018 | $2,930,000 | +49.6% | 1,135,517 | +27.5% | 0.01% | +100.0% |
| Q1 2018 | $1,959,000 | – | 890,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |